Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2003
11/13/2003US20030211964 Method of inhibiting pathogenicity of infectious agents
11/13/2003US20030211553 Selectively-expressed epitope on the human CD38 molecule detected by a phage display library-derived human scFv antibody fragment
11/13/2003US20030211513 Intracellular signaling proteins
11/13/2003US20030211493 Comprises membrane protein for diagnosis, prevention and treatment of infections, cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory and metabolic disorders
11/13/2003US20030211477 Carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1) structure and uses thereof in drug identification and screening
11/13/2003US20030211468 Comprises monoclonal antibody which deactivates kaposi's sarcoma associated herpesvirus interleukin-6 (KSRV VIL-6) for treating, diagnosing and prognosing oncogenic viral infections; antiarthritic agents; antitumor agents
11/13/2003US20030211467 Using monoclonal antibody for diagnosis, prevention and treatment of viral infections; immunotherapy; genetic vaccine
11/13/2003US20030211180 Viricides, anticancer agents; side effect reduction
11/13/2003US20030211163 Combination antiviral therapy
11/13/2003US20030211161 Anhydrous mixture of polyalcohol and insulation gel; dysmenorrhea
11/13/2003US20030211159 Gaseous extraction of solvent
11/13/2003US20030211127 Controlled dissolution crosslinked prote in crystals
11/13/2003US20030211114 Vaccine for Pseudomonas aeruginosa
11/13/2003US20030211104 Methods of using cytokine antagonists to treat HIV infection and AIDS
11/13/2003US20030211103 Use of primate IFN-gamma binding molecules
11/13/2003US20030211077 Stimulanting hematopoiesis
11/13/2003US20030211074 Synergistic mixture of polyacrolein and isothiazolin-3-one compounds
11/13/2003CA2749172A1 Re-epithelializing pharmaceutical compositions comprising xanthan gum
11/13/2003CA2703698A1 Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent
11/13/2003CA2500134A1 Methods of simultaneously treating mucositis and fungal infection
11/13/2003CA2491708A1 Non-viral gene delivery system
11/13/2003CA2485098A1 Use of heat shock proteins to enhance efficacy of antibody therapeutics
11/13/2003CA2485093A1 Substituted imidazole derivatives: gabaa receptor ligands
11/13/2003CA2484959A1 Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same
11/13/2003CA2484940A1 Methods and compositions for the modification of nucleic acids
11/13/2003CA2484921A1 Nucleoside derivatives for treating hepatitis c virus infection
11/13/2003CA2484874A1 Monocompartment osmotic controlled drug delivery system
11/13/2003CA2484597A1 Thiazolidinones and the use thereof as polo-like kinase inhibitors
11/13/2003CA2484551A1 Smart pro-drugs of serine protease inhibitors
11/13/2003CA2484329A1 Warming and nonirritating anhydrous lubricant compositions
11/13/2003CA2484312A1 Catechin multimers as therapeutic drug delivery agents
11/13/2003CA2484209A1 Protein kinase modulators and methods of use
11/13/2003CA2484189A1 Methionine aminopeptidase-2 inhibitors and methods of use thereof
11/13/2003CA2484185A1 Site specific listeria integration vectors and methods for using the same
11/13/2003CA2484173A1 4-azasteroid derivatives as androgen receptor modulators
11/13/2003CA2484095A1 Tricyclic macrolide antibacterial compounds
11/13/2003CA2484087A1 Antibacterial compounds with improved pharmacokinetic profiles
11/13/2003CA2484065A1 Inhibitors of histone deacetylase
11/13/2003CA2483917A1 Formulations limiting spread of pulmonary infections
11/13/2003CA2483909A1 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
11/13/2003CA2483846A1 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
11/13/2003CA2483806A1 N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders
11/13/2003CA2483787A1 Melanocortin receptor ligands
11/13/2003CA2483785A1 Combination of cyclooxygenase-2 inhibitors and thalidomide for the treatment of neoplasia
11/13/2003CA2483653A1 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
11/13/2003CA2483538A1 Bicyclic 6-alkylidene-penems as .szlig.-lactamases inhibitors
11/13/2003CA2482806A1 Phthalazinone derivatives
11/13/2003CA2482784A1 Composition for treating cancer containing n,n-dimethylphytosphingosine
11/13/2003CA2480777A1 Methods of using cytokine antagonists to treat hiv infection and aids
11/12/2003EP1361426A1 Method of detecting substance inhibiting type iii secretion mechanism of bacterium and the function of secretory protein thereof
11/12/2003EP1361268A1 Pax-5-deficient pro-B cells, methods of producing them and the use of such cells in human therapy
11/12/2003EP1361227A2 [5-carboxamide or 5-fluoro]-[2', 3'-unsaturated or 3'-modifield]-pyrimidine nucleosides
11/12/2003EP1361225A1 Compounds substituted with bicyclic amino groups
11/12/2003EP1361210A2 Novel immunotherapeutic agents and their use in the reduction of cytokine levels
11/12/2003EP1360498A2 Latent human tuberculosis model, diagnostic antigens, and methods of use
11/12/2003EP1360486A2 Screening method for identifying compounds that selectively induce interferon alpha
11/12/2003EP1360295A2 Molecules for desease detection and treatment
11/12/2003EP1360293A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
11/12/2003EP1360203A1 Antibodies to non-functional p 2 x 7 receptor diagnosis and treatment of cancers and other conditions
11/12/2003EP1360189A1 Formulation of boronic acid compounds
11/12/2003EP1360175A1 1g(a)-amino-n-hydroxy-acetamide derivatives
11/12/2003EP1360173A2 Trisubstituted carbocyclic cyclophilin binding compounds and their use
11/12/2003EP1360167A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use
11/12/2003EP1359975A1 Ocular iontophoretic device and method of use
11/12/2003EP1359941A2 Albumin-based drug delivery system and antimicrobial peptides
11/12/2003EP1359937A1 Altered peptide ligands
11/12/2003EP1359930A2 Novisprins: antimicrobial peptides
11/12/2003EP1359924A1 Endotoxin binding by lactic acid bacteria and bifidobacteria
11/12/2003EP1359923A1 Use of selenite or preparations containing selenite for treating wounds
11/12/2003EP1359922A1 Novel receptors for $i(helicobacter pylori) and use thereof
11/12/2003EP1359917A1 Thioxazinoquinolones useful for the treatment of viral infections
11/12/2003EP1359908A1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents
11/12/2003EP1282614B1 Hydroxamic acid derivatives
11/12/2003EP1280813B1 Anti-viral pyrimidine nucleoside analogues
11/12/2003EP1255564B1 Pharmaceutical composition comprising squalene epoxidase inhibitor and macrolide immunomodulator
11/12/2003EP1240164B1 Benzazole derivatives and their use as jnk modulators
11/12/2003EP1206444B1 Compounds that inhibit tryptase activity
11/12/2003EP1181286B1 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides
11/12/2003EP1178819B1 Glutathione reductase for therapy and prophylaxis of aids
11/12/2003EP1159005B1 Pharmaceutical combination of antiviral agents
11/12/2003EP1140937B1 Antiviral nucleoside analogues
11/12/2003EP1017278B1 Use of quaternary carboxylic acid alkanolamine ester salts as microbicide agents
11/12/2003EP0994904B1 Amino acid sequences for therapeutical and prophylactic applications to diseases due to clostridium difficile toxins
11/12/2003EP0970100B1 Benzimidazole derivatives
11/12/2003EP0513336B1 New variants derived from interferons of type i, production process thereof and their applications
11/12/2003CN1455816A Rescue of canine distemper virus from CDNA
11/12/2003CN1455779A Clycerophosphoinositol derivatives as modulators of cytosolic phospholipase
11/12/2003CN1455683A Drugs for diagnosis of tissue-reproductive activity or treatment of proliferative disease
11/12/2003CN1455674A Use of sheep's parapoxvirus bacterial strain for preparing anti-virus medicines and anti-cancer medicine
11/12/2003CN1455673A Antibiotics from bacteria isolated from amphibian skin and biological active extrat derivated from same
11/12/2003CN1455671A Methods for delaying recurrence of herpes virus symptoms
11/12/2003CN1455666A Externally-applicated chewing gum including chip-like center
11/12/2003CN1455662A Dental care compositions
11/12/2003CN1454901A Gynaecological anti-infective specificity IgY and its combined preparation
11/12/2003CN1454668A Anti-hepatitis-B-virus therapeutic vaccine and its adjuvant
11/12/2003CN1454666A Medicine composition, preparing method thereof and its use for preparing medicines for curing SARS and SARS-induced cardio-cerebro complication
11/12/2003CN1454665A Chinese medicine for preventing and curing SARS cirus
11/12/2003CN1454664A Liver-recovering capsule
11/12/2003CN1454663A Compound artemisia rupestris capsule
11/12/2003CN1454661A Medicine for curing hepatitis B and preparing method thereof
1 ... 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 ... 1798